This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05020236
Brief Title: MagnetisMM-5: Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (MAGNETISMM-5)
First Submitted : August 11, 2021
First Submitted that Met QC Criteria : August 18, 2021
First Posted : August 25, 2021
Last Update Submitted that Met QC Criteria : August 22, 2023
Last Update Posted : August 24, 2023